Genome-Based Advances in Modeling Renal Ciliopathies and Enhancing Patient Care

Area of Science:

• Nephrology
• Genetics
• Genomics

Background:

• Genetic kidney disorders (GKDs) affect over 300 million people globally, presenting diagnostic challenges and limited therapeutic options.
• GKDs are the primary cause of early-onset chronic kidney disease (CKD) and contribute significantly to kidney replacement therapy in adults.
• Ciliopathies, a category of GKDs, involve primary ciliary dysfunction and often lead to multiorgan issues, with CKD being a major cause of mortality.

Purpose of the Study:

• To review the impact of genomic technology advancements on the study and clinical management of genetic kidney disorders.
• To evaluate the benefits of genomic technologies in modeling renal diseases, particularly ciliopathies.
• To assess improvements in patient care for GKDs due to genomic advancements.

Main Methods:

• Literature review of recent studies on genomic technologies and genetic kidney disorders.
• Analysis of genomic data in the context of ciliopathies and renal disease.
• Evaluation of clinical outcomes and patient management strategies influenced by genomic insights.

Main Results:

• Genomic technologies have enhanced the understanding and diagnosis of various GKDs.
• These advancements are crucial for modeling complex genetic renal diseases like ciliopathies.
• Improved diagnostic capabilities are leading to better patient care and management strategies for GKDs.

Conclusions:

• Genomic technologies offer significant benefits in understanding and managing genetic kidney disorders.
• Accurate diagnosis through genomic analysis is vital for effective patient management, especially in ciliopathies.
• Continued advancements in genomics promise further improvements in treating inherited kidney diseases.